Our team members are at the core of what makes 3D Health Solutions such a unique and fulfilling place to work. We take pride in the diversity of our staff, with each member contributing their unique skills to the projects we are working on.
The founding members have a vast collaborative experience in Veterinary Internal Medicine, Gastroenterology, Pharmacology, Toxicology, Immunology, Mathematical/Statistical Modeling and Bioengineering. Furthermore, we will include consultants in our team with expertise in porcine veterinary medicine and porcine intestinal organoids, as well as human Gastroenterologists and experts in human intestinal organoids.
Founder and President
Dr. Allenspach is an internationally-recognized Board-Certified Internist (Gastroenterologist) and serves as President and Chief Medical Officer (CMO) of 3DHS. Dr. Allenspach as 25 years of experience as an academic faculty. It was her idea to develop a more relevant 3D intestinal epithelial cell model for canine research- culminating in the first publications on canine intestinal organoids. Dr. Allenspach oversees the effective management of all technical services in R&D and those delivered to customers. Her duties include scientific oversight of the experiments, scientific guidance for assay development, ensuring healthcare regulations/safety compliance are met, and developing and managing both service and clinical trials budgets.
COLLABORATORS/ BUSINESS ADVISORS
DR. HYUN JUNG KIM
Former Founder and Scientific Advisor
Dr. Kim is a former founding member of 3D HS and an expert in design of the 3D organoid culture system and the inventor of the human “gut-on-a-chip” microfluidics device. He currently serves as scientific consultant to 3DHS.
Former Principal Investigator
Todd Atherly is a former Research Associate and Principal Investigator.
Kimberly Dao is the concurrent Research Associate and Principal Investigator.
Steve Carter's previous positions include, among others, President of the ISU Research Park and Director of the Iowa State's Pappajohn Center for Entrepreneurship for the last 20 years. Steve was also interim director of the ISU small business development center, providing services and mentoring for strategic planning on early stage business development. Under his leadership, the ISU Research Park has grown to an asset valued in excess of $72 million and annual revenues of $8.5 million, employing >2500 individuals in Iowa. Several start-up companies achieved liquidity through acquisition or internal growth, including multiple animal health companies acquired by Boehringer Ingelheim and Merck.
Steve has been mentoring the founders from time of participating in the start-up factory program until now. Steve helps with Networking, providing access to funding and developing 3D HS' early business strategy until a CEO will be hired.
Kris Johansen currently serves as a Program Manager for the ISU I-Corps program and is the Director of the ISU Startup Factory.
Mike Roof was the Executive Director of Bio-R&D at Boehringer Ingelheim (BI) for 20 years. He has a degree in microbiology and business management and has been implemental in BI’s development of their vaccine portfolio. Mike serves as a business advisor on 3D HS’ Board and participates in monthly meetings to discuss business strategies and make connections to other biotech and biopharmaceutical companies.
Joel Harris is the current Co-Director of the Ag Startup Engine fund (ASE). ASE is VC firm focusing on angel investment into start-up companies in the midwest. Formerly he was the Director of Product at GlobalVetLINK and prior to that was VP of Harrisvaccines which was acquired by Merck Animal Health in November of 2015. Along with coordinating investor relations and mentoring at the ASE, he participates in several advisory and mentoring roles to entrepreneurs and startups in the Biotech and Healthcare industries between Chicago, Iowa City, and Ames. Joel holds a degree in economics from the University of Iowa and serves as a business adviser on the Board of 3D HS.